Skip to main content
HR 5343 115th Congress House

Prescription Transparency Act of 2018

Official title: To amend the Public Health Service Act to nullify certain contractual provisions prohibiting or penalizing a pharmacist's disclosure of the availability of the… Show full official titleShow less

Official title: To amend the Public Health Service Act to nullify certain contractual provisions prohibiting or penalizing a pharmacist's disclosure of the availability of therapeutically equivalent alternative drugs, or alternative methods of purchasing the prescription drug, that are less expensive, and for other purposes.

Introduced: June 19, 2018 Introduced by: Carter, Earl L. "Buddy" Republican · Georgia See on congress.gov
Health Business ethicsConsumer affairsContracts and agencyDrug therapy
More subjectsShow fewer subjects
Health care costs and insuranceHealth personnelMedical ethicsPrescription drugs
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 23, 2018
Referred to the Subcommittee on Health.
Mar 20, 2018
Referred to the House Committee on Energy and Commerce.
Mar 20, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 23, 2018

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Prescription Transparency Act of 2018

This bill prohibits contract provisions between a health insurer and a pharmacy that prohibit or penalize a pharmacist's disclosure to an individual purchasing a prescription drug of information regarding (1) the cost of the drug, (2) the availability of any therapeutically equivalent alternative drug, or (3) less expensive methods of purchasing the drug.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5343: Prescription Transparency Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5343/
MLA
"H.R. 5343: Prescription Transparency Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5343/.
Bluebook (legal)
H.R. 5343, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5343/.
Markdown link
[H.R. 5343: Prescription Transparency Act of 2018](https://openamerica.io/bill/115-HR-5343/)
Report a problem